Redo transcatheter aortic valve replacement in degenerated transcatheter bioprosthesis (TAV-in-TAV)

References

• Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017 Apr 6;376(14):1321–1331. doi: 10.1056/NEJMoa1700456
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1695–1705. doi: 10.1056/NEJMoa1814052
   PubMed Web of Science ®Google Scholar
• Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1706–1715. doi: 10.1056/NEJMoa1816885
   PubMed Web of Science ®Google Scholar
• Bourguignon T, El Khoury R, Candolfi P, et al. Very long-term outcomes of the Carpentier-Edwards perimount aortic valve in patients aged 60 or younger. Ann Thorac Surg. 2015 Sep;100(3):853–859. doi: 10.1016/j.athoracsur.2015.03.105
   PubMed Web of Science ®Google Scholar
• Desai PV, Goel SS, Kleiman NS, et al. Transcatheter aortic valve implantation: long-term outcomes and durability. Methodist Debakey Cardiovasc J. 2023;19(3):15–25. doi: 10.14797/mdcvj.1201
   PubMedGoogle Scholar
• Tarantini G, Sathananthan J, Fabris T, et al. Transcatheter aortic valve replacement in failed transcatheter bioprosthetic valves. JACC: Cardiovasc Interv. 2022 Sep 26;15(18):1777–1793. doi: 10.1016/j.jcin.2022.07.035
   PubMed Web of Science ®Google Scholar
• Writing C V-3, Genereux P, Piazza N, et al. Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021 May 14;42(19):1825–1857. doi: 10.1093/eurheartj/ehaa799
   PubMed Web of Science ®Google Scholar
• Patel SP, Garcia S, Sathananthan J, et al. Structural valve deterioration in transcatheter aortic bioprostheses: diagnosis, pathogenesis, and treatment. Struct Heart. 2023 May;7(3):100155. doi: 10.1016/j.shj.2022.100155
   PubMedGoogle Scholar
• Fukui M, Bapat VN, Garcia S, et al. Deformation of transcatheter aortic valve prostheses: implications for hypoattenuating leaflet thickening and clinical outcomes. Circulation. 2022 Aug 9;146(6):480–493. doi: 10.1161/CIRCULATIONAHA.121.058339
   PubMed Web of Science ®Google Scholar
• Kostyunin AE, Yuzhalin AE, Rezvova MA, et al. Degeneration of bioprosthetic heart valves: update 2020. J Am Heart Assoc. 2020 Oct 20;9(19):e018506. doi: 10.1161/JAHA.120.018506
   PubMed Web of Science ®Google Scholar
• Hirji SA, Percy ED, McGurk S, et al. Incidence, characteristics, predictors, and outcomes of surgical explantation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2020 Oct 20;76(16):1848–1859. doi: 10.1016/j.jacc.2020.08.048
   PubMed Web of Science ®Google Scholar
• Jawitz OK, Gulack BC, Grau-Sepulveda MV, et al. Reoperation after transcatheter aortic valve replacement: an analysis of the society of thoracic surgeons database. JACC: Cardiovasc Interv. 2020 Jul 13;13(13):1515–1525. doi: 10.1016/j.jcin.2020.04.029
   PubMed Web of Science ®Google Scholar
• Brescia AA, Deeb GM, Sang SLW, et al. Surgical explantation of transcatheter aortic valve bioprostheses: a statewide experience. Circ Cardiovasc Interv. 2021 Apr;14(4):e009927. doi: 10.1161/CIRCINTERVENTIONS.120.009927
   PubMed Web of Science ®Google Scholar
• Bapat VN, Zaid S, Fukuhara S, et al. Surgical explantation after TAVR failure: mid-term outcomes from the EXPLANT-TAVR international registry. JACC: Cardiovasc Interv. 2021 Sep 27;14(18):1978–1991. doi: 10.1016/j.jcin.2021.07.015
   PubMed Web of Science ®Google Scholar
• Percy ED, Harloff MT, Hirji S, et al. Nationally representative repeat transcatheter aortic valve replacement outcomes: report from the centers for medicare and medicaid services. JACC: Cardiovasc Interv. 2021 Aug 9;14(15):1717–1726. doi: 10.1016/j.jcin.2021.06.011
   PubMed Web of Science ®Google Scholar
• Tang GHL, Zaid S, Kleiman NS, et al. Explant vs redo-TAVR after transcatheter valve failure: mid-term outcomes from the EXPLANTORREDO-TAVR international registry. JACC: Cardiovasc Interv. 2023 Apr 24;16(8):927–941. doi: 10.1016/j.jcin.2023.01.376
   PubMed Web of Science ®Google Scholar
• Blanke P, Weir-McCall JR, Achenbach S, et al. Computed tomography imaging in the context of transcatheter aortic valve implantation (Tavi)/transcatheter aortic valve replacement (TAVR): an expert consensus document of the society of cardiovascular computed tomography. JACC Cardiovasc Imaging. 2019 Jan;12(1):1–24. doi: 10.1016/j.jcmg.2018.12.003
   PubMed Web of Science ®Google Scholar
• De Backer O, Landes U, Fuchs A, et al. Coronary access after TAVR-in-TAVR as evaluated by multidetector computed tomography. JACC: Cardiovasc Interv. 2020 Nov 9;13(21):2528–2538.
   PubMed Web of Science ®Google Scholar
• Nai Fovino L, Scotti A, Massussi M, et al. Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after TAVR-in-TAVR. J Am Heart Assoc. 2020 Jul 7;9(13):e016446. doi: 10.1161/JAHA.120.016446
   PubMed Web of Science ®Google Scholar
• Tarantini G, Fabris T, Nai Fovino L. TAVR-in-TAVR and coronary access: importance of preprocedural planning. EuroIntervention. 2020 Jun 12;16(2):e129–e132. doi: 10.4244/EIJ-D-19-01094
   PubMed Web of Science ®Google Scholar
• Tang GHL, Zaid S, Gupta E, et al. Feasibility of repeat TAVR after SAPIEN 3 TAVR: a novel classification scheme and pilot angiographic study. JACC: Cardiovasc Interv. 2019 Jul 8;12(13):1290–1292. doi: 10.1016/j.jcin.2019.02.020
   PubMed Web of Science ®Google Scholar
• Greenbaum AB, Kamioka N, Vavalle JP, et al. Balloon-assisted BASILICA to facilitate redo TAVR. JACC: Cardiovasc Interv. 2021 Mar 8;14(5):578–580. doi: 10.1016/j.jcin.2020.10.056
   PubMed Web of Science ®Google Scholar
• Beneduce A, Khokhar AA, Curio J, et al. Comparison of BASILICA and balloon-assisted BASILICA coronary protection for redo-TAVR: insights from bench testing. JACC: Cardiovasc Interv. 2023 Jun 12;16(11):1431–1433. doi: 10.1016/j.jcin.2023.04.031
   PubMed Web of Science ®Google Scholar
• Pirelli L, Basman CL, Brinster DR, et al. Surgical resection of prosthetic valve leaflets under direct vision (SURPLUS) for redo TAVR. JACC: Cardiovasc Interv. 2021 May 10;14(9):1036–1037. doi: 10.1016/j.jcin.2021.02.026
   PubMed Web of Science ®Google Scholar
• Tarantini G, Delgado V, de Backer O, et al. Redo-transcatheter aortic valve implantation using the SAPIEN 3/Ultra transcatheter heart valves-expert consensus on procedural planning and techniques. Am J Cardiol. 2023 Apr 1;192:228–244. doi: 10.1016/j.amjcard.2023.01.010
   PubMed Web of Science ®Google Scholar
• Akodad M, Sellers S, Landes U, et al. Balloon-expandable valve for Treatment of Evolut valve failure: implications on neoskirt height and leaflet overhang. JACC: Cardiovasc Interv. 2022 Feb 28;15(4):368–377. doi: 10.1016/j.jcin.2021.12.021
   PubMed Web of Science ®Google Scholar
• Barbanti M, Webb JG, Tamburino C, et al. Outcomes of redo transcatheter aortic valve replacement for the treatment of postprocedural and late occurrence of paravalvular regurgitation and transcatheter valve failure. Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.116.003930
   Web of Science ®Google Scholar
• Landes U, Webb JG, De Backer O, et al. Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am Coll Cardiol. 2020 Apr 28;75(16):1882–1893. doi: 10.1016/j.jacc.2020.02.051
   PubMed Web of Science ®Google Scholar
• Testa L, Agnifili M, Van Mieghem NM, et al. Transcatheter aortic valve replacement for degenerated transcatheter aortic valves: the TRANSIT international project. Circ Cardiovasc Interv. 2021 Jun;14(6):e010440. doi: 10.1161/CIRCINTERVENTIONS.120.010440
   PubMed Web of Science ®Google Scholar
• Landes U, Richter I, Danenberg H, et al. Outcomes of redo transcatheter aortic valve replacement according to the initial and subsequent valve type. JACC: Cardiovasc Interv. 2022 Aug 8;15(15):1543–1554. doi: 10.1016/j.jcin.2022.05.016
   PubMed Web of Science ®Google Scholar
• Makkar RR. Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study. The Lancet. (2023). doi: 10.1016/S0140-6736(23)01636-7
   PubMedGoogle Scholar
• Ribeiro HB, Rodes-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J. 2018 Feb 21;39(8):687–695. doi: 10.1093/eurheartj/ehx455
   PubMed Web of Science ®Google Scholar
• Rodes-Cabau J, Ellenbogen KA, Krahn AD, et al. Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC scientific Expert panel. J Am Coll Cardiol. 2019 Aug 27;74(8):1086–1106. doi: 10.1016/j.jacc.2019.07.014
   PubMed Web of Science ®Google Scholar